Status:

COMPLETED

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Lead Sponsor:

Korea University Guro Hospital

Collaborating Sponsors:

Novartis

Conditions:

Influenza, Human

Pneumococcal Infections

Eligibility:

All Genders

65+ years

Phase:

PHASE4

Brief Summary

Similar to children, adults frequently visit outpatient clinics to get two or more kinds of vaccines at the same time: pneumococcal vaccine, influenza vaccine, Td (diphtheria and tetanus) vaccine, HPV...

Detailed Description

During influenza season, concomitant influenza and pneumococcal vaccination would be an effective strategy to enhance pneumococcal vaccine coverage rate in high-risk adults. However, the immunogenicit...

Eligibility Criteria

Inclusion

  • At least 65 years of age who are eligible for the study vaccines;
  • Who have given written informed consent at the time of enrollment);
  • Those who are available for all the visits scheduled in the study;
  • Subjects In good health as determined by medical history, physical examination and clinical judgment of the investigator

Exclusion

  • History of egg allergy
  • History of influenza vaccination in previous 6 months
  • History of any pneumococcal vaccination
  • Documented S. pneumonia infection in the previous 5 years
  • Chemotherapy for malignancy within the past 30 days
  • High-dose systemic steroid (prednisone ≥0.5 mg/kg/day) in the past 30 days
  • Receipt of blood product within 6 months before enrollment
  • Significant acute or chronic infection within the previous 7 days or fever within the previous day
  • Any serious chronic or progressive disease
  • Any condition that might interfere with the study results.

Key Trial Info

Start Date :

October 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

224 Patients enrolled

Trial Details

Trial ID

NCT02225327

Start Date

October 1 2013

End Date

January 1 2014

Last Update

August 27 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine | DecenTrialz